Frank Proch Email

Sr. Director R&D . Advanced NanoTherapies

Current Roles

Employees:
17
Revenue:
$2.1M
About
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
Advanced NanoTherapies Address
16185 Los Gatos Blvd
Los Gatos, CA
Advanced NanoTherapies Email

Past Companies

Advanced NanoTherapies, IncSr. Director R&D
Cleveland ClinicInnovation Manager
Schwartz Biomedical, LLC / BioPoly, LLCDirector of Engineering and Quality

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.